| Income Statement |
| Total Revenue | 373.88M |
|
| Revenues (USD) | 373.88M |
| Cost of Revenue | 324.07M |
| Gross Profit | 49.81M |
| Operating Expenses | 30.66M |
| Research and Development Expense | 10.61M |
| Selling, General and Administrative Expense | 20.08M |
| Operating Income | 19.15M |
| Interest Expense | 2.15M |
| Income Tax Expense | -2.11M |
| Net Income | 19.11M |
| Net Income Common Stock | 19.11M |
| Net Income Common Stock (USD) | 19.11M |
| Consolidated Income | 19.11M |
| Earnings per Basic Share | 0.33 |
| Earnings per Basic Share (USD) | 0.33 |
| Earnings per Diluted Share | 0.33 |
| Earning Before Interest & Taxes (EBIT) | 19.15M |
| Earning Before Interest & Taxes (USD) | 19.15M |
| Weighted Average Shares | 57.19M |
| Weighted Average Shares Diluted | 57.93M |
| Balance Sheet |
| Cash and Equivalents | 128.32M |
| Cash and Equivalents (USD) | 128.32M |
| Trade and Non-Trade Receivables | 181.23M |
| Current Assets | 316.61M |
| Property, Plant & Equipment Net | 23.71M |
| Total Assets | 721.30M |
| Total Debt | 74.91M |
| Current Liabilities | 259.97M |
| Debt Non-Current | 74.91M |
| Total Liabilities | 398.21M |
| Accumulated Retained Earnings (Deficit) | -44.47M |
| Accumulated Other Comprehensive Income | -268.00K |
| Shareholders Equity | 323.09M |
| Shareholders Equity (USD) | 323.09M |
| Assets Non-Current | 404.69M |
| Total Debt (USD) | 74.91M |
| Goodwill and Intangible Assets | 327.71M |
| Liabilities Non-Current | 138.24M |
| Trade and Non-Trade Payables | 109.46M |
| Tax Assets | 47.32M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 8.52M |
| Net Cash Flow from Financing | -23.30M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 26.27M |
| Capital Expenditure | -797.00K |
| Issuance (Purchase) of Equity Shares | -14.64M |
| Net Cash Flow from Investing | -3.60M |
| Net Cash Flow from Operations | 53.15M |
| Effect of Exchange Rate Changes on Cash | 19.00K |
| Share Based Compensation | 10.19M |